«Berlin-Chemie» develops, produces and sells pharmaceutical products. «Berlin-Chemie» is a German subsidiary of the «Menarini Group», which has been occupying a leading position in the Italian pharmaceutical market for many years. The company, which was formed in 1886 and is headquartered in Florence, was developed over the generations to become a global, owner-managed pharmaceutical company.

 

«Menarini» pursues two strategic objectives: research and internationalisation. Both endeavours enable innovative products to be used successfully to the satisfaction of patients throughout the world. The «Menarini Group» enjoys an outstanding reputation worldwide as an efficient and reliable partner. This applies both to the development of new drugs and to the communication of scientific insights.

 

«Berlin-Chemie» also benefits from this partnership-based way of thinking. We consistently carry on the group strategy in our remit.

 

The «Menarini Group» traditionally takes advantage of the opportunity to round off its portfolio of drugs developed in-house by forming partnerships with other pharmaceutical companies and in-licensing interesting products.

 

Our long-standing experience and the success of joint projects have made the «Menarini Group» a preferred cooperation partner. The subsidiary «Berlin-Chemie/Menarini» represents the Group in Germany and Eastern Europe. Because of the very different nature of the German pharmaceutical market and those of Eastern Europe, the business is separated into two units: «Berlin-Chemie/Menarini» Germany and «Berlin-Chemie/Menarini» International Division.

 

• Berlin-Chemie/Menarini Germany
• Berlin-Chemie/Menarini International

 

Our research is centred on the development of innovative drugs for the following areas:

 

• Inflammatory diseases and pain
• Cardiovascular diseases
• Oncology
• Viral disease.